No. 14 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark ...

No. 10 / 2025 Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in ...

Copenhagen, Denmark, June 2, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with ...

In commodities, Brent crude climbed 0.5% to $64.95 a barrel, and WTI crude rose 0.7% to $62.93 a barrel. The European benchmark price for natural gas, the Dutch futures contract TTF, was up 0.2% to 35 ...

Zealand Pharma has suffered another setback in its bid to bring glucagon receptor agonist dasiglucagon for ultra-rare disease congenital hyperinsulinism (CHI) to the US market. For the second time ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neuren Pharmaceuticals Limited (NURPF – Research Report), GlaxoSmithKline (GSK – Research Rep ...

A live webcast of the fireside chat will be available to the general public and can be accessed at ...

Alvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar ...

Drug pricing has been under increased scrutiny under both the Trump and Biden administrations, including changes to cap ...

Explainer - The government announced in the Budget a plan to allow 12-month prescription renewals. But how will it work?